 |
|
ANTI-AGING
BIOMEDICINE.
HIGH TECH BIO-MEDICAL TECHNOLOGIES FOR DISEASE TREATMENT
AND LIFE EXTENSION.
EXPERIMENTAL AND CLINICAL DATA.
|
|
 |
| |
|
|
| |
| |
|
Blood flow through arteries
represents a very complex, fluid-structure interaction
(FSI) problem. Strong coupling between the blood and
artery is due to the relatively low stiffness of the
artery compared to that of blood. Hence, the pressure
exerted by the flowing blood on the artery wall can
result in considerable deformations of the artery,
and vice-versa, arterial deformations can in turn
affect the blood flow. In the present work, the finite
volume method is employed to solve the problem where
compressible fluid, representing blood, flows in healthy
arteries as well as in unhealthy, i.e., partly stiffened
arteries. The stiffening of the arterial wall is assumed
to be the first key stage in the development of atherosclerosis.
The comparison between various deformation profiles
of healthy and unhealthy arteries demonstrates significant
and measurable differences, in particular in the radial
direction. This is hoped to help toward establishing
procedures for early diagnosis of the disease.
|
|
|
Neurologischen Klinik und Poliklinik,
Universitat Wurzburg.
The diagnosis of multiple sclerosis
is primarily based on clinical criteria considering
the dissemination of neurological symptoms in time
and space. Laboratory tests (magnetic resonance imaging,
examination of cerebrospinal fluid, and evoked potentials)
are important to confirm the diagnosis and assess
disease activity. With the improvement of these methods,
MS could be diagnosed at a very early stage of the
disease allowing for the prompt initiation of immunotherapies.
An early diagnosis and prediction of the future course
of MS are also important for adequate counselling
of the predominantly young patients about their professional
plans. However, in the early stages of MS, prediction
of disability remains difficult even if the patient
is definitely diagnosed to suffer from MS.
|
|
|
Klinik fur Psychotherapie und
Psychosomatik, Rheinische Landes- und Hochschulklinik,
Essen.
The results from 1000 patients
included in a consecutive sample of older persons
showing signs of "age-related memory deficits"
clearly demonstrate the necessity for a wide spectrum
of differential diagnostic competence. The patients
included in the study were diagnosed in succession
by an interdisciplinary team of psychiatrists, neurologists,
geriatric medical specialists, psychologists and gerontologists.
The diagnostic process for clarification of DSM-III-R
and ICD-10 criteria are discussed in detail. In all,
49.6% of the patients were diagnosed as suffering
from dementia of the Alzheimer type, 31% from vascular
dementia and 10% from a mixed form. In all, 12.5%
of the patients were somatically ill and 31.4% displayed
other psychiatric conditions, 50% of which were evaluated
as being treatable with psychotherapy. The results
are primarily discussed for their relevance to the
reality of current treatment.
|
|
|
Centre de Medecine preventive
cardiovasculaire et Unite INSERM U 28, Hopital Broussais,
Paris.
The authors present a new strategy
for cardiovascular disease prevention based on risk
factor detection in occupational medicine and silent
atherosclerosis detection in a specialized investigation
centre. Employees from several firms in the Paris
region were searched, in their working place, for
cardiovascular risk factors, including blood cholesterol
measurement. The subjects at risk thus selected underwent
non-invasive explorations aimed at an early detection
of silent atherosclerosis. Extracoronary plaques in
the carotid, aorta and femoral arteries were detected
by high-resolution ultrasonography, and coronary calcifications
by ultrafast CT. The prevalence of arterial lesions
and their relationship with risk factors were analysed
in a subgroup of 208 untreated male subjects with
high blood cholesterol level: 74 percent of these
subjects had extracoronary plaques and 65 percent
had coronary calcifications. This high prevalence
of silent arterial lesions suggested that hypercholesterolaemia,
even when moderate, has an early but inconsistent
atherogenic effect. Moreover, extracoronary plaques
and coronary calcifications were related to risk factors
other than blood lipids, and among these factors age
was predominant. The simultaneous detection of extracoronary
and coronary lesions has demonstrated that extracoronary
ultrasonography of several arteries is a good diagnostic
test predicting the presence of coronary calcifications
in the absence of coronary symptoms. Detection of
silent atherosclerosis in subjects at risk therefore
is an original and helpful complement to risk factor
detection. It should better refine and individualize
the diagnosis of risk and evaluate the effects of
preventive cardiovascular treatments on atherosclerosis.
|
|
|
Department of Pathology, New York University Medical
Center.
Before 1950, there was no clear
perception of the interrelationship of serum lipids,
atherosclerosis, and coronary heart disease. Since
then, research laboratories have made conflicting
claims for the most useful measurement of the serum
lipid levels in detecting and managing coronary heart
disease. Emphasis has been placed in turn on the measurement
of levels of serum cholesterol, lipoproteins, triglycerides,
and, currently, cholesterol and lipoproteins again.
Physical separation and characterization of serum
lipoproteins by ultracentrifugation and electrophoresis
resulted in two classification systems for lipoproteins
based on hydrated density and electrophoretic mobility,
respectively. Two operational by-products were the
atherogenic index, an empirical formula supposed to
correlate with coronary heart disease, and a phenotype
system for classification of the lipoproteinemias.
Current National Heart, Lung, and Blood Institute
criteria for atherosclerosis risk implicate elevated
levels of cholesterol and low-density lipoprotein
cholesterol, and decreased levels of high-density
lipoprotein cholesterol. Although triglycerides are
closely associated with cholesterol in lipoprotein
molecules and are positively associated with cardiovascular
disease, there is no strong evidence of elevated levels
of plasma triglycerides as an independent risk factor
in coronary heart disease. Elevated levels of triglycerides
can help identify persons with increased risk of cardiovascular
disease from other causes, but screening for hypertriglyceridemia
is not recommended. Apolipoproteins and lipoprotein
Lp(a) are briefly discussed.
|
|
|
|
|
| |
|
|
|